Enanta Pharmaceuticals News

Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kowalsky Matthew Paul

May 1 16:32 ET

Enanta Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Kowalsky Matthew Paul

May 1 16:28 ET

Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Vance Terry

Mar 8 17:32 ET

Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Russell Lesley

Mar 8 17:31 ET

Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Peterson Kristine

Mar 8 17:27 ET

Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Hata Yujiro S

Mar 8 17:23 ET

Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director FOLETTA MARK G

Mar 8 17:17 ET

Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director CARTER BRUCE L A

Mar 8 17:16 ET

Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gardiner Nathaniel S.

Feb 27 18:37 ET

Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Luu Brendan

Feb 14 20:28 ET

Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kieffer Tara Lynn

Feb 14 20:23 ET

Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gardiner Nathaniel S.

Feb 14 20:23 ET

Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Rottinghaus Scott T.

Feb 14 20:18 ET

Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Or Yat Sun

Feb 14 20:18 ET

Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer MELLETT PAUL J

Feb 14 20:13 ET

Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Luly Jay R.

Feb 14 20:03 ET

Enanta Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(9.80%),Steven Boyd(9.80%)

Feb 14 15:30 ET

Enanta Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(8.52%)

Feb 13 18:00 ET

Enanta Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Joshua J. Dapice(9.6%),Philip D. Dreyfuss(9.6%), etc.

Jan 26 09:14 ET

Enanta Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(9.2%)

Jan 24 17:30 ET